| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | BIOTECNOLOGÍA | 55,446561 | 12/12/2025 | 26,97% | 56,76% | **** |
| GOLDMAN SACHS GLOBAL CORE EQUITY PORTFOLIO E (SNAP) EUR CAP | RVI GLOBAL | 47,700000 | 12/12/2025 | 6,64% | 56,75% | **** |
| PRINCIPAL GIF ORIGIN GLOBAL EMERGING MARKETS FUND F2 USD ACC | RVI EMERGENTES | 16,383940 | 12/12/2025 | 30,13% | 56,75% | **** |
| T.ROWE GLOBAL VALUE EQUITY FUND IH (EUR) | RVI GLOBAL VALOR | 15,241667 | 12/12/2025 | 24,02% | 56,75% | **** |
| CHALLENGE NORTH AMERICAN EQUITY LH-A | RVI USA | 19,262000 | 12/12/2025 | 10,11% | 56,74% | **** |
| DWS INVEST II GLOBAL EQUITY HIGH CONVICTION LD | RVI GLOBAL | 371,260000 | 12/12/2025 | 13,60% | 56,73% | **** |
| FRANKLIN U.S. OPPORTUNITIES A (ACC) SGD | RVI USA CRECIMIENTO | 28,438490 | 12/12/2025 | -5,62% | 56,72% | ** |
| JPM US SELECT EQUITY D (ACC) EUR (HEDGED) | RVI USA | 310,420000 | 12/12/2025 | 10,10% | 56,72% | **** |
| BGF JAPAN FLEXIBLE EQUITY X2 GBP | RVI JAPÓN | 26,234744 | 12/12/2025 | 7,76% | 56,69% | **** |
| FRANKLIN DISRUPTIVE COMMERCE N (ACC) EUR | CONSUMO | 7,380000 | 12/12/2025 | -4,90% | 56,69% | **** |
